How much is the patent transfer? Case analysis of patent transfer

How much is the patent transfer? Case study of patent transfer; the transfer of patent for invention at sky-high price is not necessarily a bad thing. The example of patent transfer at sky-high price is not a fantasy. How much affluent life can the patent transfer generally make the applicant live? Let's take a look at those shocking cases. Hengrui Pharmaceutical Patent Transfer Case: On September 1 2065438, jiangsu hengrui Pharmaceutical Co., Ltd. (hereinafter referred to as Hengrui Pharmaceutical) reached an agreement with Incyte Corp of the United States to license the PD- 1 monoclonal antibody (code SHR 12 10) with independent intellectual property rights to Incyte of the United States. The agreement is based on down payment and milestone payment, with a total amount of 795 million US dollars, and promotional activities are counted separately. Cinda biopharmaceutical patent transfer case: Lilly Pharmaceutical Company of the United States and Cinda biopharmaceutical (Suzhou) Co., Ltd. (hereinafter referred to as Cinda biopharmaceutical) recently announced the expansion of their existing cooperation in drug research and development, which is also one of the biggest cooperation between China biopharmaceutical companies and multinational pharmaceutical companies. This cooperation involves three new bispecific tumor immunotherapy antibodies, all of which adopt PD- 1 monoclonal antibodies independently developed by Cinda Biopharmaceutical. According to the cooperation agreement, Cinda Bio-Pharmaceutical and Lilly will cooperate in the research, development, production and sales of the above-mentioned new drugs, among which Cinda Bio-Pharmaceutical will cooperate to lead the research, development, production and sales in China market, and Lilly will cooperate to lead the research, development, production and sales in foreign markets. Based on this new cooperation, Cinda Bio-Pharmaceutical will receive a milestone payment of more than US$ 654.38 billion from Lilly Pharmaceutical Company of the United States. If the above antibodies are commercialized abroad, Cinda Bio-Pharmaceutical will also receive additional sales commission and other funds. Personal patent transfer case: The first domestic low-cost 3D printing and polishing machine developed by a graduate student of Chongqing Institute of Science and Technology won a patent transfer fee of 2 million yuan through the bidding of CCTV science and education channel Inventing DreamWorks. Patent transfer case of Shanghai Academy of Biological Sciences: 20 10, Shanghai Academy of Biological Sciences (hereinafter referred to as Shanghai Academy of Biological Sciences) licensed the patent right of an anti-tumor drug invented by protein to Sanofi-Aventis, a multinational pharmaceutical company, with a license contract amount of more than 60 million US dollars and an extra commission on sales revenue.